Article Versions Notes

Blokhin ME, Borisov SA, Gromova MA, Meshkova YV, Zhukova NA, Nikonova SV, Zhurakovsky IP, Luzina OA, Khvostov MV, Kudlay DA, et al. Isopimaric Acid Derivatives as Potential Dual PPARα/γ Agonists in the Treatment of Metabolic Syndrome. Scientia Pharmaceutica. 2025; 93(3):44. https://doi.org/10.3390/scipharm93030044

Blokhin, Mikhail E., Sergey A. Borisov, Mariia A. Gromova, Yulia V. Meshkova, Nataliya A. Zhukova, Sophia V. Nikonova, Igor P. Zhurakovsky, Olga A. Luzina, Mikhail V. Khvostov, Dmitry A. Kudlay, and et al. 2025. "Isopimaric Acid Derivatives as Potential Dual PPARα/γ Agonists in the Treatment of Metabolic Syndrome" Scientia Pharmaceutica 93, no. 3: 44. https://doi.org/10.3390/scipharm93030044

Blokhin, M. E., Borisov, S. A., Gromova, M. A., Meshkova, Y. V., Zhukova, N. A., Nikonova, S. V., Zhurakovsky, I. P., Luzina, O. A., Khvostov, M. V., Kudlay, D. A., & Salakhutdinov, N. F. (2025). Isopimaric Acid Derivatives as Potential Dual PPARα/γ Agonists in the Treatment of Metabolic Syndrome. Scientia Pharmaceutica, 93(3), 44. https://doi.org/10.3390/scipharm93030044